DARLA GRAHAM: Open Payments
NPI 1700841053 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 63 payments from 13 companies in 2025. Trend: 2023 $641 · 2024 $1,113 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 37 | $312 |
| ABBVIE INC. | 12 | $149 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Omnipod, CRENESSITY, ACTHAR, SYNTHROID, Yorvipath, TARPEYO, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across KS — which companies pay providers there.
